<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01317147</url>
  </required_header>
  <id_info>
    <org_study_id>PRO07120162</org_study_id>
    <nct_id>NCT01317147</nct_id>
  </id_info>
  <brief_title>The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors</brief_title>
  <official_title>The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Society for Metabolic and Bariatric Surgery</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The morbidly obese frequently present with mood and anxiety disorders, which are often
      treated with serotonin reuptake inhibitors (SRI) antidepressant drugs. The investigators
      hypothesized that gastric bypass surgery would decrease the absorption of SRI. The
      investigators also wished to determine whether a reduction in SRI levels would increase the
      likelihood of worsening depressive symptoms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twelve RYGB candidates who were successfully treated with an SRI for primary mood or anxiety
      disorders were studied prospectively. Blood samples for SRI plasma levels were drawn
      immediately after dose for pharmacokinetic studies (PK) preoperatively. Maximum concentration
      (CMAX), time to CMAX (TMAX), and Area Under Concentration/Time curve (AUC) were determined.
      PK studies were repeated at one, six, and twelve months post-operatively. PK data were
      corrected for dose at each study time point. The Structured Interview Guide for the Hamilton
      Depression Rating Scale— Atypical Depression Symptom Version was used to quantify depressive
      symptoms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Gastric Bypass</condition>
  <condition>Depression</condition>
  <condition>Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>Gastric bypass patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Roux-en-Y gastric bypass (RYGBP)</intervention_name>
    <arm_group_label>Gastric bypass patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Bariatric surgery clinic- Morbidly obese patients seeking RYGB who met criteria for
        bariatric surgery (BMI ≥ 40 kg/m2 or ≥ 35 kg/m2 with severe obesity-related comorbidities)
        and were received maintenance treatment with an SRI for primary mood or anxiety disorder.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to tolerate general anesthesia

          -  Able to document prior unsuccessful attempts at weight loss under medical supervision
             during the last 6 months

          -  Able to provide informed consent

          -  Cleared for surgery by primary care MD, dietician, and psychiatrist

          -  SRI treatment specifically for depression for ≥6 wks at constant dose for last 2 out
             of 6 wks

        Exclusion Criteria:

          -  pregnancy

          -  Unwilling or unable to comply with postoperative requirements for diet, supplements,
             exercise, or followup
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giselle Hamad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW. Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2003 Dec 15;158(12):1139-47.</citation>
    <PMID>14652298</PMID>
  </reference>
  <reference>
    <citation>Sarwer DB, Cohn NI, Gibbons LM, Magee L, Crerand CE, Raper SE, Rosato EF, Williams NN, Wadden TA. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg. 2004 Oct;14(9):1148-56.</citation>
    <PMID>15527626</PMID>
  </reference>
  <reference>
    <citation>Alciati A, D'Ambrosio A, Foschi D, Corsi F, Mellado C, Angst J. Bipolar spectrum disorders in severely obese patients seeking surgical treatment. J Affect Disord. 2007 Aug;101(1-3):131-8. Epub 2007 Jan 16.</citation>
    <PMID>17229468</PMID>
  </reference>
  <reference>
    <citation>Ali MR, Rasmussen JJ, Monash JB, Fuller WD. Depression is associated with increased severity of co-morbidities in bariatric surgical candidates. Surg Obes Relat Dis. 2009 Sep-Oct;5(5):559-64. doi: 10.1016/j.soard.2008.10.015. Epub 2008 Nov 21.</citation>
    <PMID>19342306</PMID>
  </reference>
  <reference>
    <citation>Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010 Oct;71(10):1259-72. doi: 10.4088/JCP.09r05346blu. Review.</citation>
    <PMID>21062615</PMID>
  </reference>
  <reference>
    <citation>Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Med Sci. 2006 Apr;331(4):219-25. Review.</citation>
    <PMID>16617238</PMID>
  </reference>
  <reference>
    <citation>Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm. 2006 Oct 1;63(19):1852-7. Review.</citation>
    <PMID>16990631</PMID>
  </reference>
  <reference>
    <citation>Pihlajamäki J, Grönlund S, Simonen M, Käkelä P, Moilanen L, Pääkkönen M, Pirinen E, Kolehmainen M, Kärjä V, Kainulainen S, Uusitupa M, Alhava E, Miettinen TA, Gylling H. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding. Metabolism. 2010 Jun;59(6):866-72. doi: 10.1016/j.metabol.2009.10.004. Epub 2009 Dec 16.</citation>
    <PMID>20015521</PMID>
  </reference>
  <reference>
    <citation>Ruz M, Carrasco F, Rojas P, Codoceo J, Inostroza J, Rebolledo A, Basfi-fer K, Csendes A, Papapietro K, Pizarro F, Olivares M, Sian L, Westcott JL, Hambidge KM, Krebs NF. Iron absorption and iron status are reduced after Roux-en-Y gastric bypass. Am J Clin Nutr. 2009 Sep;90(3):527-32. doi: 10.3945/ajcn.2009.27699. Epub 2009 Jul 22.</citation>
    <PMID>19625680</PMID>
  </reference>
  <reference>
    <citation>Roerig JL, Steffen K, Zimmerman C, Mitchell JE, Crosby RD, Cao L. Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort. Surg Obes Relat Dis. 2012 Jan-Feb;8(1):62-6. doi: 10.1016/j.soard.2010.12.003. Epub 2010 Dec 15.</citation>
    <PMID>21256091</PMID>
  </reference>
  <reference>
    <citation>Skottheim IB, Stormark K, Christensen H, Jakobsen GS, Hjelmesaeth J, Jenssen T, Reubsaet JL, Sandbu R, Asberg A. Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients. Clin Pharmacol Ther. 2009 Sep;86(3):311-8. doi: 10.1038/clpt.2009.82. Epub 2009 Jun 3.</citation>
    <PMID>19494810</PMID>
  </reference>
  <reference>
    <citation>Brolin RE. Update: NIH consensus conference. Gastrointestinal surgery for severe obesity. Nutrition. 1996 Jun;12(6):403-4. Review.</citation>
    <PMID>8875533</PMID>
  </reference>
  <reference>
    <citation>First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders—patient edition. : New York State Psychiatric Institute; 1996.</citation>
  </reference>
  <reference>
    <citation>Williams JBW, Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale with Ayptical Depression Supplement (SIGH-ADS). New York: New York State Psychiatric Institute; 2003.</citation>
  </reference>
  <reference>
    <citation>Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000 Oct;232(4):515-29.</citation>
    <PMID>10998650</PMID>
  </reference>
  <reference>
    <citation>Gubbins PO, Bertch KE. Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet. 1991 Dec;21(6):431-47. Review.</citation>
    <PMID>1782738</PMID>
  </reference>
  <reference>
    <citation>Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010 Jan;11(1):41-50. doi: 10.1111/j.1467-789X.2009.00614.x. Epub 2009 Jun 2. Review.</citation>
    <PMID>19493300</PMID>
  </reference>
  <reference>
    <citation>Magee SR, Shih G, Hume A. Malabsorption of oral antibiotics in pregnancy after gastric bypass surgery. J Am Board Fam Med. 2007 May-Jun;20(3):310-3.</citation>
    <PMID>17478665</PMID>
  </reference>
  <reference>
    <citation>Wills SM, Zekman R, Bestul D, Kuwajerwala N, Decker D. Tamoxifen malabsorption after Roux-en-Y gastric bypass surgery: case series and review of the literature. Pharmacotherapy. 2010 Feb;30(2):217. doi: 10.1592/phco.30.2.217. Review.</citation>
    <PMID>20099995</PMID>
  </reference>
  <reference>
    <citation>Behrns KE, Smith CD, Sarr MG. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci. 1994 Feb;39(2):315-20.</citation>
    <PMID>8313814</PMID>
  </reference>
  <reference>
    <citation>Seaman JS, Bowers SP, Dixon P, Schindler L. Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model. Psychosomatics. 2005 May-Jun;46(3):250-3.</citation>
    <PMID>15883146</PMID>
  </reference>
  <reference>
    <citation>Brandacher G, Winkler C, Aigner F, Schwelberger H, Schroecksnadel K, Margreiter R, Fuchs D, Weiss HG. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obes Surg. 2006 May;16(5):541-8.</citation>
    <PMID>16687019</PMID>
  </reference>
  <reference>
    <citation>Bodnar LM, Wisner KL. Nutrition and depression: implications for improving mental health among childbearing-aged women. Biol Psychiatry. 2005 Nov 1;58(9):679-85. Epub 2005 Jul 25. Review.</citation>
    <PMID>16040007</PMID>
  </reference>
  <reference>
    <citation>Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet. 2010;49(2):71-87. doi: 10.2165/11318100-000000000-00000. Review.</citation>
    <PMID>20067334</PMID>
  </reference>
  <reference>
    <citation>Kinzl JF, Schrattenecker M, Traweger C, Mattesich M, Fiala M, Biebl W. Psychosocial predictors of weight loss after bariatric surgery. Obes Surg. 2006 Dec;16(12):1609-14.</citation>
    <PMID>17217637</PMID>
  </reference>
  <reference>
    <citation>Legenbauer T, De Zwaan M, Benecke A, Muhlhans B, Petrak F, Herpertz S. Depression and anxiety: their predictive function for weight loss in obese individuals. Obes Facts. 2009;2(4):227-34. doi: 10.1159/000226278. Epub 2009 Aug 17.</citation>
    <PMID>20054228</PMID>
  </reference>
  <reference>
    <citation>Clark MM, Niaura R, King TK, Pera V. Depression, smoking, activity level, and health status: pretreatment predictors of attrition in obesity treatment. Addict Behav. 1996 Jul-Aug;21(4):509-13.</citation>
    <PMID>8830908</PMID>
  </reference>
  <reference>
    <citation>Rusch MD, Andris D. Maladaptive eating patterns after weight-loss surgery. Nutr Clin Pract. 2007 Feb;22(1):41-9. Review.</citation>
    <PMID>17242453</PMID>
  </reference>
  <reference>
    <citation>Sanchez-Santos R, Del Barrio MJ, Gonzalez C, Madico C, Terrado I, Gordillo ML, Pujol J, Moreno P, Masdevall C. Long-term health-related quality of life following gastric bypass: influence of depression. Obes Surg. 2006 May;16(5):580-5.</citation>
    <PMID>16687025</PMID>
  </reference>
  <reference>
    <citation>Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007 Aug 23;357(8):753-61.</citation>
    <PMID>17715409</PMID>
  </reference>
  <reference>
    <citation>Reis M, Aberg-Wistedt A, Agren H, Akerblad AC, Bengtsson F. Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations. J Affect Disord. 2004 Nov 1;82(3):443-6.</citation>
    <PMID>15555696</PMID>
  </reference>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2011</study_first_submitted>
  <study_first_submitted_qc>March 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2011</study_first_posted>
  <last_update_submitted>March 15, 2011</last_update_submitted>
  <last_update_submitted_qc>March 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Giselle Hamad, MD Assistant Professor of Surgery</name_title>
    <organization>University of Pittsburgh School of Medicine</organization>
  </responsible_party>
  <keyword>pharmacokinetics</keyword>
  <keyword>serotonin reuptake inhibitors</keyword>
  <keyword>gastric bypass</keyword>
  <keyword>depression</keyword>
  <keyword>bioavailability</keyword>
  <keyword>drug absorption</keyword>
  <keyword>area under curve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Serotonin</mesh_term>
    <mesh_term>Serotonin Uptake Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

